SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Booms, Busts, and Recoveries -- Ignore unavailable to you. Want to Upgrade?


To: EL KABONG!!! who wrote (38342)9/17/2003 5:58:35 AM
From: TobagoJack  Read Replies (1) | Respond to of 74559
 
Hi KJC, <<A Small Victory In Treating SARS Stirs Big Hopes

Toronto Doctor Rushed Trial For a Promising New Remedy: A Version of Drug Interferon>>

My reactions are: oh good, hmmn, oops, should I buy back my China/HK shares.

My decision is: let us sit tight, trigger ready, wait and see.

Chugs, Jay



To: EL KABONG!!! who wrote (38342)9/17/2003 10:41:44 AM
From: smolejv@gmx.net  Respond to of 74559
 
Read this in Nature: Fast vaccine offers hope in battle with Ebola - Similar vaccines could form part of future emergency strategy (7 August 2003)

nature.com


....

The possibility of fast-acting vaccines should nevertheless prompt a rethink of vaccination strategy at times when rapid responses are needed to viral bioweapons or novel viruses such as that which causes severe acute respiratory syndrome (SARS), says Nabel. "This could change our thinking about how we use vaccines," he says.



To: EL KABONG!!! who wrote (38342)9/17/2003 4:31:55 PM
From: RealMuLan  Respond to of 74559
 
Interferon has been used regularly in the treatment of SARS in China in last spring (as well as in all kinds of cancers). And it has been effective to certain degree, not quite as effective as some herbal combination. So Chinese would not throw the money away just to do a large-scale clinical trial<g>